Noveltreat 2.4 mg Pre-filled Pen
In stock
Description
Sematrinity 4 mg/3 mL Injection is a prescription medication developed by Sun Pharmaceutical Industries in India (launched March 2026) containing the active ingredient semaglutide.It is a GLP-1 receptor agonist designed for the management of type 2 diabetes and sometimes used for weight management, administered as a once-weekly subcutaneous injection .
Specifications
| Strength | 2.4 mg |
|---|---|
| Dosage Form | Pre-filled Multi-dose Pen |
| Injection Site | Subcutaneous (under the skin) in the abdomen, thigh, or upper arm |
| Storage | Store in a refrigerator (2 - 8°C). Do not freeze |
| Active Ingredients | Semaglutide (4mg in 3 mL} Solution) |
